BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

91 hedge funds and large institutions have $154M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
91
Holders Change
+3
Holders Change %
+3.41%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
23
Reduced
32
Closed
13
Calls
$1.18M
Puts
$1.61M
Net Calls
-$425K
Net Calls Change
-$2.12M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$11.4M
2
Millennium Management
2
Millennium Management
New York
$1.05M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$19.7M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$498K
5
VFA
5
Virtus Fund Advisers
Connecticut
$343K

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$2.13M
3
Citadel Advisors
3
Citadel Advisors
Florida
$811K
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$22.1M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$2.45M
Name Holding Trade Value Shares
Change 		Shares
Change %
EWM
101
Edge Wealth Management
New York
– -$8K -70 Closed
MAM
102
Meeder Asset Management
Ohio
– -$1K -9 Closed
1 2 3 4
5